TABLE 2.
Basic characteristics of each group
Beta blockers | ACE inhibitors | Angiotensin receptor blockers | Calcium channel blocker | Thiazide diuretics | p value | |
---|---|---|---|---|---|---|
Number | 133 | 124 | 79 | 76 | 78 | – |
Age (< 50/50‐60/60‐70/≥70) | 4%/16%/36%/44% | 5%/31%/36%/27% | 5%/24%/46%/25% | 3%/25%/37%/36% | 5%/17%/41%/37% | .10 |
Sex (male percentage) | 36% | 50% | 39% | 26% | 27% | .003 |
BMI | 28.99± 4.57 | 30.37 ± 4.82 | 30.18± 4.93 | 30.44 ±4.06 | 29.63 ± 4.85 | .10 |
Charlson comorbidity score | 0.42 ± 0.83 | 0.48 ± 0.97 | 0.54 ± 1.04 | 0.42 ± 0.79 | 0.33 ± 0.72 | .62 |
KL grade (2/3/4) | 53%/38%/5% | 58%/30%/10 % | 57%/35%/8% | 57%/33%/7% | 58%/32%/9% | .85 |
Drug use frequency (regular/as need) | 123/10 | 110/14 | 72/7 | 68/8 | 62/15 | .10 |